HomeNewsBusinessStocksBuy Ajanta Pharma; target of Rs 239.90: Swastika Investmart
Trending Topics
Sensex Live
US India Trade Deal
Silver ETFs
Income Tax Calculator 2026
Gold Rate Today

Buy Ajanta Pharma; target of Rs 239.90: Swastika Investmart

Swastika Investmart is bullish on Ajanta Pharma and has recommended buy rating on the stock with a target of Rs 239.90 in its February 10, 2011 research report.

February 11, 2011 / 16:02 IST
Story continues below Advertisement
Remove Ad

Swastika Investmart is bullish on Ajanta Pharma and has recommended buy rating on the stock with a target of Rs 239.90 in its February 10, 2011 research report.

Read More

first published: Feb 11, 2011 03:55 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Follow Us On: Facebook twitter instagram linkedin youtube
Trending Topics
Sensex Today India US Trade Deal Gold Silver Rate Today Delhi Fog Indian Rupee Sergio Gor India-US trade deal impact Silver ETF Zerodha App Gold Silver ETF
News
Business Markets Stocks India News City News Economy Mutual Funds Personal Finance IPO News Startups
Markets
Home Currencies Commodities Pre-Market IPO Global Market Bonds Silver MCX Price Gold MCX Price
Personal Finance
Home Loans up to 50 Lakhs Credit Cards Lifetime Free Finance Tracker New Fixed Deposits Fixed Deposit Comparison Fixed Income
Mutual Funds
Home MC 30 Top Ranked Funds ETFs Mutual Fund Screener
Tools
Income Tax Calculator EMI Calculator Retirement Planning Gratuity Calculator Petrol Price in India Diesel Price in India IFSC Code
Community
Stock Markets
Network 18 Sites
News18 Firstpost CNBC TV18 News18 Hindi Cricketnext Overdrive
Quick Links
About Us Contact Us Advisory Alert Advertise with Us Disclaimer Privacy Policy Cookie Policy Terms & Conditions Financial Terms (Glossary) Sitemap Investors
Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.